February 7th 2025
Development of new modalities of biotherapeutic molecules will rely on manufacturing, regulatory, and collaborative support.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Nexcella Begins Production of CAR-T Cell Therapy Engineering Batches at US Manufacturing Site
May 31st 2023The start of production of US engineering batches of NXC-201, a CAR-T cell therapy candidate in early clinical development, is the first step in transferring Nexcella’s existing manufacturing process to the United States.
Drug Digest: Advancements in the Implementation of Continuous Manufacturing
May 29th 2023In this episode of Drug Digest, Pharmaceutical Technology editors discuss the advantages and savings that continuous manufacturing may offer as well as the very real obstacles that might make a fully continuous process not feasible, especially in biologics manufacturing.
TriLink BioTechnologies to Expand Manufacturing Capabilities
May 24th 2023The new CGMP facility is expected to contribute to the development of mRNA therapeutics, with a building designed for the CGMP manufacture of mRNA-based in-vivo gene editing, gene-edited cell therapies, protein replacement therapies, cancer vaccines, and infectious disease vaccines.